KRT14 and breast cancer: Several breast cancer mouse models have shown that shRNA-mediated KRT14 knockdown or diphtheria toxin-mediated ablation of KRT14+ tumour cells resulted in smaller primary tumours and significantly fewer metastatic lesions [65,71].